Shochat T 1, Hadas N 1, Molotsky A1,
Sohir Suraiya2 , Peled R 2 and Lavie P
2
1-Scientific Laboratory Products, Ltd., Tel Aviv,
2 Sleep Medicine Center, Rambam Medical Center, Haifa.
Presented at the ISRS meeting, 2002
Introduction: Sleep Bruxism (SB) is characterized by
involuntary grinding and clenching of teeth during sleep. The
movements are rhythmic or tonic contractions of the masseter and other
jaw muscles. Patients are usually unaware of the condition, and bed
partners or roommates usually complain of the unpleasant noise.
Symptoms include abnormal wearing of teeth, temporomandibular joint (TMJ)
dysfunction or pain, chewing difficulties, headaches and daytime
sleepiness. The prevalence of SB is 8% in the adult population. SB
is diagnosed based on clinical examination of the teeth, complaints of
jaw and masticatory pain, and subjective reports by the bed partner or
family member, of the grinding and clenching noise. Currently there
is no “gold standard” for a definitive, objective diagnosis. Due to
high costs of PSG in-lab recordings, patients suspected of SB are not
routinely referred to the sleep laboratory. In light of the need for
an efficient, low cost, automated objective screening device able to
monitor bruxism episodes at night, Scientific Laboratory Products
(SLP) Ltd. have developed the BiteStrip®. This screener is a small,
lightweight device attached to the cheek, over the TMJ. The BiteStrip®
consists of two pre-gelled EMG electrodes, real time analysis hardware
and software, a miniature display unit and a lithium battery. The
device detects the bruxism events, computes their total amount and
displays a score (the “Bscore”) in the morning. The purpose of this
study was to validate the BiteStrip® against polysomnographic
recordings with masseter EMG.
Methods: 11 consecutive patients age 18-45 referred to the
sleep lab for sleep disorders of any kind participated. Patients
underwent full PSG recordings including masseter EMG in the sleep
laboratory concomitantly with the use of the BiteStrip® for a single
night. Bscores were collected and masseter EMG scored by experienced
PSG scorers. Due to the small number of subjects, Spearman rank
correlations were computed for the in-lab Bscores against the PSG-determined
total number of bruxism events (EMG). Furthermore, to rule out sleep
apnea as a third factor causing the EMG signal, correlations were
computed between Bscore and the respiratory disturbance index (RDI).
Finally, to assess the relations between bruxism and sleep,
correlations were computed between the Bscore and sleep efficiency
(SE).
Results: One out of 10 subjects did not complete the study,
as the BiteStrip® was removed from this subject early in the night.
For the remaining 10 subjects (see table 1) the correlation between
EMG and Bscore was: r=0.96 (p<0.001). Insignificant correlations were
found between Bscore and RDI (r=0.44, p<0.2) as well as between Bscore
and SE (r=-0.37, p<0.3).
Table 1: Spearman correlations (r) and p values
EMG
RDI
SE
Bscore
0.96 (p<0.001)
0.44 (p<0.2)
-0.37 (p<0.3)
Conclusions:
Despite the small number of subjects, an excellent correlation was
found between traditional PSG derived EMG recordings and the Bscore
derived by the BiteStrip®. This was not related to movements caused
by sleep apnea. The relationship between bruxism and sleep quality
remains unclear, and deserves further investigation. We conclude that
the BiteStrip® may be an excellent tool for patients and doctors of
patients suspected of Bruxism.